DrugsControl Media Services

News Detail

Identifying and Treating Factors Associated with Erythropoietin Resistance (09-11-2023)

Mexico, 8 Nov 2023: Patients with end-stage kidney disease with anemia are commonly treated with recombinant human erythropoietin. However, according to Juan Daniel Diaz Garcia and colleagues at Centro Medico Nacional 20 Noviembre, Mexico City, Mexico, vario......
View Details

Source : Docwire News
recombinant human erythropoietin

Related News